| Literature DB >> 30386536 |
Elnaz Daneshzad1, Shaghayegh Emami2,3, Manije Darooghegi Mofrad1, Sahar Saraf-Bank2, Pamela J Surkan4, Leila Azadbakht1,5,2.
Abstract
Introduction: Cardiovascular disease (CVD) is one of the most important causes of mortality. Healthy diets can decrease CVDs and other chronic diseases especially in patients with type 2 diabetes. In this study, we investigate association between adherence to the modified Nordic diet and cardiovascular risk factors among patients with type 2 diabetes.Entities:
Keywords: Cardiovascular Risk Factors; Diabetic Patient; Dietary Pattern; Nordic Diet; Type 2 Diabetes
Year: 2018 PMID: 30386536 PMCID: PMC6203863 DOI: 10.15171/jcvtr.2018.25
Source DB: PubMed Journal: J Cardiovasc Thorac Res ISSN: 2008-5117
Demographic characteristics of diabetic patients in different tertiles of the adherence to the Nordic diet (N = 339)
|
|
|
|
| ||
|
|
|
| |||
|
| 339 | 42 | 162 | 135 | - |
| Sex (n) | |||||
| Male | 217 | 24 | 102 | 91 | 0.446 |
| Female | 122 | 18 | 60 | 44 | |
| Age (y) | 60.37 ± 13.20 | 57.14 ± 15.16 | 60.83 ± 12.84 | 60.82 ± 12.94 | 0.239 |
| Weight (kg) | 70.88 ± 12.54 | 71.61 ± 13.23 | 68.70 ± 12.59 | 73.28 ± 11.88 | 0.007 |
| 71.78 ± 1.89 | 68.87 ± 0.93 | 72.95 ± 1.04 | 0.013b | ||
| BMI (kg/m2) | 25.57 ± 4.13 | 26.93 ± 5.39 | 24.88 ± 3.88 | 25.96 ± 3.85 | 0.006 |
| 26.79 ± 0.63 | 24.93 ± 0.31 | 25.95 ± 0.34 | 0.010b | ||
| Waist Circumference (n)d | |||||
| Men >102 cm | 16 | 1 | 4 | 11 | 0.084 |
| Men ≤ 102 cm | 201 | 22 | 97 | 80 | |
| Women >88 cm | 62 | 12 | 24 | 26 | 0.054 |
| Women ≤88 cm | 60 | 6 | 36 | 18 | |
| Physical activity | |||||
| Low | 65.8% | 27 | 117 | 79 | 0.108c |
| Moderate | 31.9% | 15 | 41 | 52 | |
| High | 2.4% | 0 | 4 | 4 | |
| SES (n) | |||||
| Poor | 19.5% | 18 | 36 | 12 | <0.0001 |
| Moderate | 66.1% | 24 | 105 | 95 | |
| Rich | 14.5% | 0 | 21 | 28 | |
Abbreviations: BMI: body mass index; SES: Socio-economic status
Data are presented as Mean ± SD or number of individuals.
a P values presented resulted from analysis of one-way ANOVA and Chi-square test for quantitative and qualitative variables.
b P values presented resulted from ANCOVA analysis and were adjusted for age, sex, and SES.
c P values resulted from Fisher exact test.
d Mean WC was lower in highest tertiles of Nordic diet adherence, however, this was non-significant. Data are not shown.
Dietary intakes of participants in different tertiles of the adherence to the Nordic dietary pattern scores (n = 339)
|
|
|
| ||
|
|
|
| ||
| Energy (kcal/d) | 1296 ± 224.57 | 1429 ± 114.70 | 1787 ± 125.26 | 0.052 |
| Carbohydrate (g/d) | 273.1 ± 6.15b | 257.2 ± 3.14 | 244.6 ± 3.44 | <0.0001 |
| Protein (g/d) | 40.19 ± 2.53 | 47.63 ± 1.29 | 54.78 ± 1.41 | <0.0001 |
| Fat (g/d) | 36.13 ± 1.80 | 39.41 ± 0.92 | 42.60 ± 1.01 | 0.004 |
| Dietary fiber (g/d) | 7.92 ± 0.75 | 9.08 ± 0.38 | 12.17 ± 0.42 | <0.0001 |
| PUFA (g/d) | 11.45 ± 0.72 | 11.83 ± 0.36 | 12.70 ± 0.40 | 0.173 |
| MUFA (g/d) | 11.06 ± 0.76 | 12.07 ± 0.38 | 13.29 ± 0.42 | 0.019 |
| SFA (g/d) | 9.90 ± 0.71 | 11.14 ± 0.36 | 11.71 ± 0.40 | 0.086 |
| Iron (mg/d) | 11.42 ± 0.92 | 13.32 ± 0.47 | 15.25 ± 0.51 | 0.001 |
| Magnesium (mg/d) | 120.29 ± 8.51 | 153.66 ± 4.34 | 181.40 ± 4.76 | <0.0001 |
| Zinc (mg/d) | 4.00 ± 0.28 | 4.96 ± 0.14 | 5.65 ± 0.16 | <0.0001 |
| Folate (mcg/d) | 137.01 ± 13.57 | 176.57 ± 6.93 | 213.38 ± 7.59 | <0.0001 |
| Potassium (mg/d) | 1486 ± 113.05 | 1878 ± 57.73 | 2262 ± 63.25 | <0.0001 |
| Phosphorus (mg/d) | 573.4 ± 46.56 | 672.1 ± 23.78 | 795.4 ± 26.05 | <0.0001 |
| Calcium (mg/d) | 560 ± 49.63 | 681 ± 25.34 | 795.1 ± 27.76 | <0.0001 |
| Vitamin C (mg/d) | 73.24 ± 9.47 | 73.31 ± 4.83 | 95.81 ± 5.30 | 0.005 |
| Vitamin E (mg/d) | 10.25 ± 1.02 | 12.21 ± 0.52 | 13.09 ± 0.57 | 0.054 |
| Vitamin B1 (mg/d) | 1.18 ± 0.07 | 1.19 ± 0.03 | 1.36 ± 0.03 | 0.004 |
| Vitamin B2 (mg/d) | 0.93 ± 0.06 | 1.10 ± 0.03 | 1.27 ± 0.03 | <0.0001 |
| Vitamin B3 (mg/d) | 13.04 ± 0.81 | 13.78 ± 0.41 | 15.43 ± 0.45 | 0.007 |
| Vitamin B6 (mg/d) | 0.64 ± 0.05 | 0.81 ± 0.02 | 0.97 ± 0.02 | <0.0001 |
| Vitamin B12 (mcg/d) | 1.44 ± 0.18 | 1.85 ± 0.09 | 2.04 ± 0.10 | 0.017 |
| α-Tocopherol (mg/d) | 4.01 ± 0.34 | 4.08 ± 0.17 | 4.52 ± 0.19 | 0.181 |
| Β-Carotene (mg/d) | 112.10 ± 58.08 | 306.13 ± 29.66 | 550.21 ± 32.49 | <0.0001 |
| Rye/ wholegrain breads (g/d) | 77.49 ± 15.08 | 127.0 ± 7.70 | 137.50 ± 8.44 | 0.003 |
| Oatmeal (g/d) | 11.50 ± 3.51 | 21.72 ± 1.79 | 34.34 ± 1.96 | <0.0001 |
| Cabbages/vegetables (g/d) | 65.97 ± 56.89 | 135.30 ± 29.05 | 250.60 ± 31.83 | 0.004 |
| Apples, pears/high antioxidant fruits (g/d) | 70.38 ± 10.56 | 86.87 ± 5.39 | 131.8 ± 5.91 | <0.0001 |
| Root vegetables (g/d) | 13.38 ± 5.29 | 42.94 ± 2.70 | 67.18 ± 2.96 | <0.0001 |
| Fish (g/d) | 0.33 ± 1.06 | 4.52 ± 0.54 | 8.35 ± 0.59 | <0.0001 |
| Sweets (g/d) | 35.18 ± 7.27 | 41.98 ± 3.71 | 43.94 ± 4.07 | 0.578 |
| Processed foods (g/d) | 0.01 ± 0.20 | 0.23 ± 0.10 | 0.32 ± 0.11 | 0.411 |
| Red meat (g/d) | 9.76 ± 1.42 | 6.49 ± 0.72 | 6.88 ± 0.79 | 0.119 |
| Dairy products (g/d) | 259.57 ± 35.77 | 308.82 ± 18.26 | 355.44 ± 20.01 | 0.044 |
| Egg (g/d) | 5.51 ± 1.34 | 8.25 ± 0.68 | 8.92 ± 0.75 | 0.086 |
Abbreviations: PUFA, poly-unsaturated fatty acids; MUFA, mono-unsaturated fatty acids; SFA, saturated fatty acids.
Energy intake is presented as mean and SD.
a Calculated by analysis of covariance (ANCOVA).
b All values from this row are adjusted for energy intake and presented as mean and SE.
Biochemical tests among diabetic patients based on different tertiles of the adherence to the Nordic dietary pattern scores (N = 339)
|
|
|
|
| ||
|
|
|
| |||
| FBS (mg/dL) | |||||
| Crude model | 111.24 ± 33.45 | 118.71 ± 35.77 | 110.22 ± 28.71 | 110.16 ± 37.69 | 0.304 |
| Model 1 | 119.77 ± 95.17 | 110.12 ± 48.23 | 109.93 ± 52.83 | 0.214 | |
| Model 2 | 118.11 ± 94.62 | 111.07 ± 48.05 | 109.30 ± 52.65 | 0.327 | |
| SBP (mm Hg) | |||||
| Crude model | 127.71 ± 17.50 | 130.95 ± 12.79 | 127.28 ± 18.83 | 127.22 ± 17.11 | 0.441 |
| Model 1 | 131.04 ± 49.89 | 127.32 ± 25.22 | 127.14 ± 27.61 | 0.423 | |
| Model 2 | 130.55 ± 50.07 | 127.79 ± 25.04 | 126.86 ± 27.79 | 0.499 | |
| DBP (mm Hg) | |||||
| Crude model | 127.71 ± 11.95 | 86.66 ± 11.45 | 82.83 ± 9.90 | 84.50 ± 14.08 | 0.146 |
| Model 1 | 86.21 ± 33.50 | 82.91 ± 16.93 | 84.55 ± 18.59 | 0.209 | |
| Model 2 | 86.09 ± 33.87 | 83.04 ± 17.30 | 84.45 ± 18.77 | 0.290 | |
| TG (mg/dL) | |||||
| Crude model | 151.78 ± 76.91 | 163.33 ± 71.41 | 140.28 ± 69.99 | 161.99 ± 84.67 | 0.031 |
| Model 1 | 161.76 ± 217.97 | 140.32 ± 110.46 | 162.42 ± 121.13 | 0.032 | |
| Model 2 | 155.18 ± 209.50 | 144.53 ± 106.59 | 159.79 ± 116.35 | 0.202 | |
| HDL (mg/dL) | |||||
| Crude model | 42.32 ± 9.70 | 41.71 ± 7.87 | 42.16 ± 8.95 | 42.70 ± 11.03 | 0.812 |
| Model 1 | 41.31 ± 26.69 | 42.10 ± 13.43 | 42.89 ± 14.72 | 0.587 | |
| Model 2 | 41.69 ± 26.51 | 41.88 ± 13.43 | 43.07 ± 14.72 | 0.499 | |
| LDL (mg/dL) | |||||
| Crude model | 94.17 ± 30.98 | 102.81 ± 29.51 | 93.98 ± 32.13 | 91.71 ± 29.73 | 0.127 |
| Model 1 | 99.98 ± 83.76 | 94.24 ± 42.34 | 92.29 ± 46.39 | 0.338 | |
| Model 2 | 99.38 ± 84.31 | 94.75 ± 42.89 | 91.98 ± 46.76 | 0.354 | |
| TC (mg/dL) | |||||
| Crude model | 181.53 ± 46.49 | 179.79 ± 33.59 | 185.84 ± 45.79 | 176.91 ± 50.42 | 0.249 |
| Model 1 | 177.02 ± 129.97 | 185.94 ± 65.90 | 177.64 ± 72.16 | 0.235 | |
| Model 2 | 176.24 ± 130.89 | 186.13 ± 66.46 | 178.04 ± 72.71 | 0.235 | |
| AST (mg/dL) | |||||
| Crude model | 32.64 ± 5.93 | 36.14 ± 6.56 | 32.88 ± 5.89 | 31.26 ± 5.29 | < 0.0001 |
| Model 1 | 36.23 ± 16.20 | 32.86 ± 8.28 | 31.26 ± 9.02 | < 0.0001 | |
| Model 2 | 36.25 ± 16.38 | 32.76 ± 8.28 | 31.41 ± 9.02 | < 0.0001 | |
| hs-CRP | |||||
| Crude model | 2.96 ± 0.50 | 2.91 ± 0.52 | 2.99 ± 0.48 | 2.94 ± 0.51 | 0.602 |
| Model 1 | 2.91 ± 1.28 | 2.99 ± 0.55 | 2.94 ± 0.73 | 0.589 | |
| Model 2 | 2.91 ± 1.28 | 2.99 ± 0.73 | 2.94 ± 0.73 | 0.507 | |
| Fibrinogen | |||||
| Crude model | 247.30 ± 18.82 | 246.43 ± 14.56 | 248.40 ± 20.44 | 246.27 ± 18.01 | 0.594 |
| Model 1 | 246.39 ± 53.94 | 248.42 ± 27.24 | 246.26 ± 29.82 | 0.586 | |
| Model 2 | 246.12 ± 54.30 | 248.23 ± 27.61 | 246.41 ± 30.19 | 0.663 | |
Abbreviations: FBS: fasting blood sugar; SBP & DBP: systolic and diastolic blood pressure; TG: triglyceride; HDL & LDL: high and low-density lipoprotein; TC: total cholesterol; AST: aspartate trance aminase; hs-CRP: high sensitive-C reactive protein.
Data presented as mean ± SD.
a P values presented resulted from ANCOVA analysis and in crude model, model 1 which adjusted for sex and age, and model 2 which adjusted for model 1 + energy intake, and BMI.
Odd ratios and 95% confidence intervals for different CVD risk factors according to tertiles of adherence to the Nordic dietary pattern (n=339)
|
|
|
| ||
|
|
|
| ||
| LDL ≥ 130 | ||||
| Crude | 1 | 0.57 (0.24-1.36) | 0.32 (0.12-0.85) | 0.020 |
| Model 1b | 1 | 0.76 (0.29-1.97) | 0.41 (0.14-1.17) | 0.074 |
| Model 2c | 1 | 0.63 (0.23-1.73) | 0.29 (0.09-0.91) | 0.025 |
| TC ≥ 200 | ||||
| Crude | 1 | 1.60 (0.73-3.49) | 0.91 (0.40-2.07) | 0.294 |
| Model 1b | 1 | 2.10 (0.92-4.76) | 1.35 (0.56-3.23) | 0.914 |
| Model 2c | 1 | 1.63 (0.68-3.87) | 0.87 (0.34-2.23) | 0.332 |
| TG ≥ 150 | ||||
| Crude | 1 | 0.48 (0.24-0.96) | 0.64 (0.32-1.28) | 0.627 |
| Model 1b | 1 | 0.50 (0.25-1.01) | 0.68 (0.33-1.40) | 0.778 |
| Model 2c | 1 | 0.47 (0.23-0.98) | 0.61 (0.28-1.30) | 0.692 |
| FBS ≥ 110 | ||||
| Crude | 1 | 0.85 (0.43-1.69) | 0.73 (0.36-1.48) | 0.356 |
| Model 1b | 1 | 0.79 (0.39-1.59) | 0.71 (0.34-1.47) | 0.379 |
| Model 2c | 1 | 0.78 (0.38-1.61) | 0.70 (0.32-1.50) | 0.464 |
| SBP ≥ 130 | ||||
| Crude | 1 | 0.45 (0.22-0.92) | 0.40 (0.19-0.82) | 0.032 |
| Model 1b | 1 | 0.42 (0.20-0.87) | 0.35 (0.17-0.74) | 0.015 |
| Model 2c | 1 | 0.52 (0.25-1.10) | 0.51 (0.23-1.12) | 0.225 |
| DBP ≥ 85 | ||||
| Crude | 1 | 0.43 (0.21-0.85) | 0.63 (0.31-1.28) | 0.770 |
| Model 1b | 1 | 0.45 (0.22-0.92) | 0.65 (0.32-1.34) | 0.785 |
| Model 2c | 1 | 0.45 (0.22-0.93) | 0.70 (0.33-1.50) | 0.889 |
| WC ≥ 88 (Women) | ||||
| Crude | 1 | 0.33 (0.11-1.01) | 0.72 (0.22-2.28) | 0.834 |
| Model 1b | 1 | 0.36 (0.11-1.10) | 0.72 (0.22-2.33) | 0.893 |
| Model 2c | 1 | 0.46 (0.13-1.61) | 1.09 (0.25-4.78) | 0.937 |
| WC ≥ 102 (Men) | ||||
| Crude | 1 | 0.93 (0.10-8.79) | 3.16 (0.38-25.79) | 0.053 |
| Model 1b | 1 | 1.12 (0.11-10.87) | 3.32 (0.39-28.30) | 0.076 |
| Model 2c | 1 | 1.23 (0.12-12.48) | 3.48 (0.39-31.01) | 0.086 |
| Obesity | ||||
| Crude | 1 | 0.09 (0.04-0.23) | 0.21 (0.10-0.47) | 0.005 |
| Model 1b | 1 | 0.10 (0.04-0.24) | 0.24 (0.10-0.54) | 0.012 |
| Model 2c | 1 | 0.10 (0.04-0.25) | 0.25 (0.10-0.63) | 0.030 |
a P values were calculated using logistic regression.
b Model 1: adjusted for age, sex and energy intake.
c Model 2: model 1 + socioeconomic status and physical activity.
Risk of high metabolic factors was defined by ATPIII guidelines: (1) abdominal obesity (WC > 88 in women and >102 in men); (2) high serum triglycerides levels (≥ 150 mg/dL); (3) elevated blood pressure (≥ 130/85 mm Hg); (4) high serum LDL-C levels (≥ 130 mg/dL); (5) abnormal serum glucose levels (FBS ≥ 110 mg/dL); (6) high serum total cholesterol levels (≥ 200 mg/dL) (6) obesity (BMI ≥ 30)